Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial

PURPOSE: Bone marrow-derived, allogeneic, multipotent adult progenitor cells demonstrated safety and efficacy in preclinical models of acute respiratory distress syndrome (ARDS). METHODS: This phase 1/2 trial evaluated the safety and tolerability of intravenous multipotent adult progenitor cells in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellingan, G., Jacono, F., Bannard-Smith, J., Brealey, D., Meyer, N., Thickett, D., Young, D., Bentley, A., McVerry, B. J., Wunderink, R. G., Doerschug, K. C., Summers, C., Rojas, M., Ting, A., Jenkins, E. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608557/
https://www.ncbi.nlm.nih.gov/pubmed/34811567
http://dx.doi.org/10.1007/s00134-021-06570-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608557/
https://www.ncbi.nlm.nih.gov/pubmed/34811567
http://dx.doi.org/10.1007/s00134-021-06570-4

Ejemplares similares